2.9(top 20%)
impact factor
777(top 20%)
papers
6.1K(top 20%)
citations
32(top 20%)
h-index
3.0(top 20%)
extended IF
783
all documents
6.9K
doc citations
58(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studiesClinical and Translational Radiation Oncology2018415
2Adaptive radiotherapy: The Elekta Unity MR-linac conceptClinical and Translational Radiation Oncology2019330
3Technical design and concept of a 0.35 T MR-LinacClinical and Translational Radiation Oncology2019210
4COVID-19: Global radiation oncology’s targeted response for pandemic preparednessClinical and Translational Radiation Oncology2020183
5Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?Clinical and Translational Radiation Oncology2018141
6Infrastructure and distributed learning methodology for privacy-preserving multi-centric rapid learning health care: euroCATClinical and Translational Radiation Oncology201798
7Relative biological effectiveness in proton beam therapy – Current knowledge and future challengesClinical and Translational Radiation Oncology201896
8Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trialsClinical and Translational Radiation Oncology201986
9Automatic treatment planning improves the clinical quality of head and neck cancer treatment plansClinical and Translational Radiation Oncology201681
10Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic reviewClinical and Translational Radiation Oncology201876
11Spatially fractionated radiation therapy: History, present and the futureClinical and Translational Radiation Oncology202072
124D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experienceClinical and Translational Radiation Oncology202071
13PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumoursClinical and Translational Radiation Oncology201866
14The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblastsClinical and Translational Radiation Oncology202064
15Healthcare ex Machina: Are conversational agents ready for prime time in oncology?Clinical and Translational Radiation Oncology201958
16The rationale for MR-only treatment planning for external radiotherapyClinical and Translational Radiation Oncology201957
17Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linacClinical and Translational Radiation Oncology202056
18Learning from scanners: Bias reduction and feature correction in radiomicsClinical and Translational Radiation Oncology201954
19Prostate cancer – Advantages and disadvantages of MR-guided RTClinical and Translational Radiation Oncology201954
20PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT statusClinical and Translational Radiation Oncology201851
21Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatmentClinical and Translational Radiation Oncology202050
22Radiomic analysis in prediction of Human Papilloma Virus statusClinical and Translational Radiation Oncology201749
23MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technologyClinical and Translational Radiation Oncology201948
24Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patientsClinical and Translational Radiation Oncology201747
25Potentials and challenges of diffusion-weighted magnetic resonance imaging in radiotherapyClinical and Translational Radiation Oncology201847
26The technical design and concept of a PET/CT linac for biology-guided radiotherapyClinical and Translational Radiation Oncology202147
27Telehealth in radiation oncology at the Townsville Cancer Centre: Service evaluation and patient satisfactionClinical and Translational Radiation Oncology201946
28Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic gliomaClinical and Translational Radiation Oncology201841
29Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trialClinical and Translational Radiation Oncology201841
30Short-course palliative radiation therapy leads to excellent bleeding control: A single centre retrospective studyClinical and Translational Radiation Oncology201939
31A review of the role of MRI in diagnosis and treatment of early stage lung cancerClinical and Translational Radiation Oncology202037
32Neutrophilia as a biomarker for overall survival in newly diagnosed high-grade glioma patients undergoing chemoradiationClinical and Translational Radiation Oncology201836
33Cardiac death after breast radiotherapy and the QUANTEC cardiac guidelinesClinical and Translational Radiation Oncology201933
34Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO)Clinical and Translational Radiation Oncology201832
35Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapyClinical and Translational Radiation Oncology201932
36Radiation for ETMR: Literature review and case series of patients treated with proton therapyClinical and Translational Radiation Oncology201932
37Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear acceleratorClinical and Translational Radiation Oncology202132
38Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapyClinical and Translational Radiation Oncology201831
39The role of biological dose-escalation for pancreatic cancerClinical and Translational Radiation Oncology201931
40Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?Clinical and Translational Radiation Oncology201930
41Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac – Feasibility, workflow data and patient acceptanceClinical and Translational Radiation Oncology202130
42Organ preservation in rectal cancer – Challenges and future strategiesClinical and Translational Radiation Oncology201729
43Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort studyClinical and Translational Radiation Oncology201729
44Evaluation of deep learning-based multiparametric MRI oropharyngeal primary tumor auto-segmentation and investigation of input channel effects: Results from a prospective imaging registryClinical and Translational Radiation Oncology202228
45Beyond checkpoint inhibition – Immunotherapeutical strategies in combination with radiationClinical and Translational Radiation Oncology201727
46Improved outcome of treating locally advanced lung cancer with the use of Lattice Radiotherapy (LRT): A case reportClinical and Translational Radiation Oncology201827
47Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRTClinical and Translational Radiation Oncology201827
48Online MR guided radiotherapy for rectal cancer. New opportunitiesClinical and Translational Radiation Oncology201927
49Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicineClinical and Translational Radiation Oncology202027
50Learning radiation oncology in Europe: Results of the ESTRO multidisciplinary surveyClinical and Translational Radiation Oncology201826